SHWGF OTC
Shandong Weigao Group Medical Polymer Company Limited
1W: +5.0%
1M: -2.3%
3M: -2.3%
YTD: -39.1%
1Y: -44.7%
3Y: -73.8%
5Y: -72.7%
$0.42
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$13.0B
-0.3% ▼
5Y CAGR: +2.3%
Gross Profit
$5.9B
-9.9% ▼
5Y CAGR: -1.7%
Operating Income
$1.8B
-23.2% ▼
5Y CAGR: -4.3%
Net Income
$1.6B
-24.0% ▼
5Y CAGR: -5.5%
EPS (Diluted)
$0.35
-22.2% ▼
5Y CAGR: -5.3%
EBITDA
$2.8B
-26.1% ▼
5Y CAGR: -2.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $13.2B | $13.6B | $13.2B | $13.1B | $13.0B |
| YoY Growth | +13.2% | +3.6% | -2.9% | -1.1% | -0.3% |
| Cost of Revenue | $5.9B | $6.5B | $6.6B | $6.5B | $7.1B |
| Gross Profit | $7.4B | $7.3B | $6.6B | $6.6B | $5.9B |
| Gross Margin | 55.9% | 53.6% | 50.2% | 50.3% | 45.5% |
| R&D Expenses | $492M | $547M | $593M | $625M | $630M |
| SG&A Expenses | $3.8B | $3.5B | $3.8B | $3.6B | $3.5B |
| Operating Expenses | $4.2B | $4.0B | $4.3B | $4.2B | $4.1B |
| Operating Income | $2.9B | $2.9B | $2.3B | $2.4B | $1.8B |
| Operating Margin | 22.0% | 21.5% | 17.4% | 18.2% | 14.0% |
| Interest Expense | $140M | $191M | $273M | $250M | $249M |
| Income Before Tax | $2.9B | $3.4B | $2.4B | $2.6B | $2.0B |
| Tax Expense | $420M | $436M | $308M | $391M | $313M |
| Net Income | $2.3B | $2.8B | $2.0B | $2.1B | $1.6B |
| Net Margin | 17.3% | 20.3% | 15.1% | 15.8% | 12.0% |
| EPS (Diluted) | $0.50 | $0.61 | $0.44 | $0.45 | $0.35 |
| EBITDA | $3.8B | $4.4B | $3.6B | $3.8B | $2.8B |
| Shares Outstanding | 4.52B | 4.53B | 4.54B | 4.55B | 4.54B |